Autors: Baltic News Service Datums: 31.05.2001 Izdevums: The Baltic TimesRubrika: Bussiness
The Lithuanian pharmaceutical company Biotechna, which produces gene-engineering medicine, is projecting a one-fifth increase in sales this year and intends to start selling its production in Western markets in 2003-2004.
Lai lasītu visu rakstu, lūdzu, ienāciet sistēmā